Synthesis and Structural Studies of Three Uracil Derivatives, Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanate, Methyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate and Ethyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)propanoate

被引：0

作者：

Liu, Wuqiang ^{[1
]}

Feng, Xiaogang ^{[1
]}

Tao, Yangyang ^{[1
]}

Zhou, Zheng ^{[1
]}

Wu, Guanghui ^{[1
]}

Xiong, Jing ^{[1
]}

机构：

[1] Wenzhou Univ, Coll Chem & Mat Engn, Wenzhou 325035, Peoples R China

来源：

JOURNAL OF CHEMICAL CRYSTALLOGRAPHY | 2014年 / 44卷 / 11-12期

关键词：

Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Methyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Ethyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Crystal structure; NMR spectra; FUNDAMENTAL FREQUENCIES; POTENT INHIBITORS; RAMAN-SPECTRA; IN-VITRO; 5-CHLOROURACIL; 5-FLUOROURACIL; MICHAEL; DESIGN; FTIR;

D O I：

10.1007/s10870-014-0554-y

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

Three uracil derivatives of methyl 3-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl) propanoate (I), methyl 3-(5-nitro- 2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) propanoate (II) and ethyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl) propanoate (III) have been prepared through one pot synthesis and examined by X-ray crystallography, FT-IR and NMR spectroscopy. Compound I, C8H10N2O4, is monoclinic with space group P 21/c and cell constants a = 11.4437(12), b = 11.7980(13), c = 6.9496(7) angstrom, beta = 103.180(2)degrees, V = 913.57(17) angstrom(3), and Z = 4. Compound II, C8H9N3O6, crystallizes in the monoclinic P 21 space group with cell constants a = 8.0342(14), b = 5.7155(10), c = 11.572(2) angstrom, beta = 105.200(3)degrees, V = 512.79(16) angstrom(3), and Z = 2. Compound III, C9H11N3O6, is Orthorhombic with space group P 212121 and cell constants a = 5.7560(16), b = 8.032(2), c = 25.302(7) angstrom, beta = 90 degrees, V = 1169.8(6) angstrom(3), and Z = 4. The supramolecular architectures of the three compounds involve N-H center dot center dot center dot O hydrogen bond.

引用

页码：597 / 603

页数：7

共 50 条

[31] Aqueous hydrolysis of 3-[2-(3-methyl-1H-pyrazol-1-yl)-ethylamino]- and 3-[2-(5-methyl-1H-pyrazol-1-yl)ethylamino]-propanoates
Attaryan, O. S.
Balayan, A. O.
Asratyan, G. B.
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2008, 78 (07) : 1425 - 1426
[32] ONE POT, THREE-COMPONENT, ENVIRONMENTALLY FRIENDLY SYNTHESIS OF NOVEL 1,4-DIOXO-3,4 - DIHYDROPHTHALAZIN -2(1H) -YL) - 4 - HETEROYL - 4H -PYRANS
Suman, M.
Vijayabhaskar, B.
Kumar, U. K. Syam
Rao, B. Venkateswara
HETEROCYCLIC LETTERS, 2018, 8 (01): : 205 - 212
[33] Synthesis and Structural Characterization of Manganese(II), Iron(III), Cobalt(II) and Copper(II) Complexes of 3-[1-(3,4-Dihydro-6-methyl-2,4-dioxo-2H-pyran-3-yl)ethylideneamino]-benzoic Acid
Mane, V. G.
ASIAN JOURNAL OF CHEMISTRY, 2011, 23 (03) : 1065 - 1068
[34] Synthesis of substituted N-[(3-(1H-pyrrol-1yl)methyl]-5,6-dihydropyridin-1(2H)-yl) benzamide/benzene sulfonamide as anticancer agents
Redda, Kinfe Ken
Gangapuram, Madhavi
Mochona, Bereket
Mateeva, Nelly
Ardley, Tiffany
CANCER RESEARCH, 2011, 71
[35] Crystal structure of isobutyl 3-(4-amino-2-oxopyrimidin-1(2H)-yl)-propanoate, C11H17N3O3
Geng, Li-Li
Wang, Chun
Yuan, Wei
Song, Xiao-Ming
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2013, 228 (04): : 447 - 448
[36] Molecular packing in (5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)acetamide
Borowiak, T
Dutkiewicz, G
Spychala, J
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2006, 62 : O344 - O345
[37] Synthesis and Antimicrobial Evaluation of 2-(6-Imidazo [1,2-a]pyridin-2-yl-5-methyl-2,4-dioxo-3-phenyl-3, 4-dihydrothieno[2,3-d]pyrimidin-1(2H)-yl)-N-arylacetamide Derivatives
Vlasov, Sergiy V.
Severina, Hanna, I
Borysov, Oleksandr, V
Krolenko, Konstantin Yu
Shynkarenko, Pavlo E.
Saidov, Narzullo B.
Vlasov, Vitaliy S.
Georgiyants, Victoriya A.
MOLBANK, 2022, 2022 (01)
[38] Synthesis of [3-[2-(dimethylamino)ethyl]-2[[3-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide -: the main sumatriptane impurity
Skwierawska, A
Paluszkiewicz, E
POLISH JOURNAL OF CHEMISTRY, 2003, 77 (03) : 329 - 332
[39] Synthesis and pharmacological characterization of the selective GluK1 radioligand (S)-2-amino-3-(6[ 3H]-2,4-dioxo-3,4-dihydrothieno.3,2-d] pyrimidin1.2H)- yl) propanoic acid ([3H]-NF608)
Alcaide, Anna
Marconi, Laura
Marek, Ales
Haym, Isabell
Nielsen, Birgitte
Mollerud, Stine
Jensen, Mikael
Conti, Paola
Pickering, Darryl S.
Bunch, Lennart
MEDCHEMCOMM, 2016, 7 (11) : 2136 - 2144
[40] CRYSTAL STRUCTURE AND PACKING FEATURES OF 3-(5-METHYL-1H-PYRAZOL-3-YL)-2H-CHROMEN-2-ONE AND 3-(3-METHYL-1H-PYRAZOL-3-YL)-2H-CHROMEN-2-ONE
Kostritskiy, A. Yu.
Dmitriev, M. V.
Grinev, V. S.
Fedotova, O. V.
JOURNAL OF STRUCTURAL CHEMISTRY, 2021, 62 (03) : 443 - 451

← 1 2 3 4 5 →